section name header

Interacting Drugs

OBJECT DRUGS

PRECIPITANT DRUGS

Enzyme Inducers:


Comment:

Inducers of CYP3A4 or P-glycoprotein may reduce the concentration of rivaroxaban. Several days to weeks may be required to see the full effect an inducer on rivaroxaban. A reduction in the anticoagulant effect may occur.


Class 3: Assess Risk & Take Action if Necessary

Monitor: Monitor for altered rivaroxaban effect if a CYP3A4 or P-glycoprotein inducer is initiated, discontinued or changed in dosage; adjustments of rivaroxaban dosage may be needed.